Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3724 |  ORMP Oramed Pharmaceuticals Inc. - Common Stock | 4.32 USD | +0.47% | -5.26% | +18.03% | +96.36% | 176.80 M USD | ||
| 3736 |  PYXS Pyxis Oncology, Inc. - Common Stock | 2.76 USD | -10.10% | -4.83% | +64.29% | +144.25% | 174.86 M USD | ||
| 3739 |  CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | 9.43 USD | +0.53% | +4.31% | +24.74% | -43.19% | 174.72 M USD | ||
| 3745 |  IPHA Innate Pharma S.A. - American Depositary Shares | 1.84 USD | -3.16% | -0.54% | +4.55% | +5.14% | 172.44 M USD | ||
| 3750 |  PRQR ProQR Therapeutics N.V. - Ordinary Shares | 1.62 USD | -2.41% | -7.95% | +4.52% | -28.00% | 170.68 M USD | ||
| 3756 |  HUMA Humacyte, Inc. - Common Stock | 0.76 USD | -1.30% | +5.56% | -44.93% | -70.99% | 168.73 M USD | ||
| 3760 |  ADCT ADC Therapeutics SA Common Shares | 1.32 USD | -3.65% | +17.86% | +34.69% | -55.56% | 167.89 M USD | ||
| 3767 |  MOLN Molecular Partners AG - American Depositary Shares | 4.09 USD | +0.74% | +5.14% | +11.44% | +13.61% | 165.13 M USD | ||
| 3791 |  ANTX AN2 Therapeutics, Inc. - Common Stock | 4.41 USD | +2.56% | -6.96% | +15.75% | +320.00% | 158.83 M USD | ||
| 3802 |  MIST Milestone Pharmaceuticals Inc. - Common Shares | 1.25 USD | -3.10% | -8.09% | +0.81% | -44.93% | 155.62 M USD | ||
| 3808 |  IFRX InflaRx N.V. - Common Stock | 2.13 USD | +0.47% | -11.62% | +22.41% | +147.67% | 153.98 M USD | ||
| 3816 |  TLSA Tiziana Life Sciences Ltd - Common Shares | 1.26 USD | 0.00% | -0.79% | +4.13% | -14.29% | 151.84 M USD | ||
| 3833 |  NRXP NRX Pharmaceuticals, Inc. - Common Stock | 4.00 USD | -3.85% | +2.30% | -7.83% | +124.72% | 144.92 M USD | ||
| 3834 |  UNCY Unicycive Therapeutics, Inc. - Common Stock | 5.42 USD | -0.18% | +11.07% | -19.94% | -16.74% | 144.71 M USD | ||
| 3838 |  CNTB Connect Biopharma Holdings Limited - American Depositary Shares | 2.27 USD | +2.71% | -4.62% | +1.79% | +94.02% | 142.93 M USD | ||
| 3843 |  YDES YD Bio Limited - Ordinary Shares | 2.00 USD | 0.00% | -11.50% | -32.20% | -75.00% | 141.58 M USD | ||
| 3846 |  HURA TuHURA Biosciences, Inc. - Common Stock | 2.21 USD | -1.34% | -13.33% | +7.80% | -10.89% | 140.74 M USD | ||
| 3847 |  PEPG PepGen Inc. - Common Stock | 2.02 USD | -1.46% | +14.77% | +50.75% | +75.65% | 139.72 M USD | ||
| 3859 |  SPRB Spruce Biosciences, Inc. - Common Stock | 49.95 USD | -1.62% | -3.52% | -1.52% | +354.09% | 137.48 M USD | ||
| 3861 |  CUE Cue Biopharma, Inc. - Common Stock | 33.88 USD | +1.47% | +15.71% | +15.36% | +4478.38% | 137.07 M USD |
Notizie Biotechnology Stocks
TD Cowen conferma il Buy su Prime Medicine dopo la vittoria nell’arbitrato
BofA conferma il rating su Beam Therapeutics dopo il lodo arbitrale
Perché il titolo Beam Therapeutics sta scendendo oggi?
Perché il titolo Prime Medicine è in forte rialzo oggi?
Il titolo di Incyte raggiunge il massimo di 52 settimane a 118,77 USD
Il titolo di Prime Medicine sale dopo la vittoria nell’arbitrato contro Beam
Nurix Therapeutics: focus sull’impatto dell’accordo con Roche
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.76 | +53.55% |
 APLMW Apollomics Inc. - Warrant | 0.0161 | +34.17% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.51 | +25.36% |
 PRME Prime Medicine, Inc. - Common Stock | 4.76 | +19.30% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.50 | +14.84% |
 VANI Vivani Medical, Inc. - Common Stock | 1.55 | +14.81% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.70 | +13.33% |
 CINGW Cingulate Inc. - Warrants | 0.0232 | +11.00% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 1.85 | -33.21% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.82 | -21.15% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0139 | -17.26% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.32 | -13.16% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 ONCO Onconetix, Inc. - Common Stock | 0.94 | -12.15% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.18 | -11.79% |